• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床医生报告不良症状事件的可靠性。

Reliability of adverse symptom event reporting by clinicians.

机构信息

Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY 10022, USA.

出版信息

Qual Life Res. 2012 Sep;21(7):1159-64. doi: 10.1007/s11136-011-0031-4. Epub 2011 Oct 8.

DOI:10.1007/s11136-011-0031-4
PMID:21984468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3633532/
Abstract

PURPOSE

Adverse symptom event reporting is vital as part of clinical trials and drug labeling to ensure patient safety and inform risk-benefit decision making. The purpose of this study was to assess the reliability of adverse event reporting of different clinicians for the same patient for the same visit.

METHODS

A retrospective reliability analysis was completed for a sample of 393 cancer patients (42.8% men; age 26-91, M = 62.39) from lung (n = 134), prostate (n = 113), and Ob/Gyn (n = 146) clinics. These patients were each seen by two clinicians who independently rated seven Common Terminology Criteria for Adverse Events (CTCAE) symptoms. Twenty-three percent of patients were enrolled in therapeutic clinical trials.

RESULTS

The average time between rater evaluations was 68 min. Intraclass correlation coefficients were moderate for constipation (0.50), diarrhea (0.58), dyspnea (0.69), fatigue (0.50), nausea (0.52), neuropathy (0.71), and vomiting (0.46). These values demonstrated stability over follow-up visits. Two-point differences, which would likely affect treatment decisions, were most frequently seen among symptomatic patients for constipation (18%), vomiting (15%), and nausea (8%).

CONCLUSION

Agreement between different clinicians when reporting adverse symptom events is moderate at best. Modification of approaches to adverse symptom reporting, such as patient self-reporting, should be considered.

摘要

目的

作为临床试验和药物标签的一部分,不良症状事件报告至关重要,以确保患者安全并为风险效益决策提供信息。本研究的目的是评估同一患者在同一就诊时不同临床医生报告不良事件的可靠性。

方法

对来自肺癌(n=134)、前列腺癌(n=113)和妇产科(n=146)诊所的 393 名癌症患者(男性占 42.8%;年龄 26-91 岁,M=62.39)的样本进行了回顾性可靠性分析。每位患者均由两位临床医生进行评估,这两位医生独立评估了七种常见不良事件术语标准(CTCAE)症状。23%的患者参加了治疗性临床试验。

结果

评估者之间的平均时间间隔为 68 分钟。便秘(0.50)、腹泻(0.58)、呼吸困难(0.69)、疲劳(0.50)、恶心(0.52)、神经病变(0.71)和呕吐(0.46)的组内相关系数为中度。这些值在随访就诊中表现出稳定性。最常出现在有症状患者中的两点差异,可能会影响治疗决策,包括便秘(18%)、呕吐(15%)和恶心(8%)。

结论

当报告不良症状事件时,不同临床医生之间的一致性充其量是中等的。应该考虑修改不良症状报告方法,例如患者自我报告。

相似文献

1
Reliability of adverse symptom event reporting by clinicians.临床医生报告不良症状事件的可靠性。
Qual Life Res. 2012 Sep;21(7):1159-64. doi: 10.1007/s11136-011-0031-4. Epub 2011 Oct 8.
2
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.患者与临床医生报告的不良症状事件:与临床结局的关系
J Natl Cancer Inst. 2009 Dec 2;101(23):1624-32. doi: 10.1093/jnci/djp386. Epub 2009 Nov 17.
3
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.使用美国国立癌症研究所不良事件通用术语标准的患者与临床医生症状报告:一项基于问卷的研究结果
Lancet Oncol. 2006 Nov;7(11):903-9. doi: 10.1016/S1470-2045(06)70910-X.
4
Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting.探索临床试验环境中临床医生与患者之间不良症状事件分级阈值的差异。
J Cancer Res Clin Oncol. 2017 Apr;143(4):735-743. doi: 10.1007/s00432-016-2335-9. Epub 2017 Jan 16.
5
Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).临床医生与患者主观不良事件评估:基于患者报告结局版通用不良事件术语标准(PRO-CTCAE)。
Qual Life Res. 2020 Nov;29(11):3009-3015. doi: 10.1007/s11136-020-02558-7. Epub 2020 Jun 20.
6
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.在肿瘤学试验的不良事件报告中引出儿童的声音:不良事件通用术语标准儿科患者报告结局版本的认知访谈结果
Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26261. Epub 2016 Sep 21.
7
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.患者自我报告的症状和临床医生的评分作为总体癌症生存的预测因素。
J Natl Cancer Inst. 2011 Dec 21;103(24):1851-8. doi: 10.1093/jnci/djr485. Epub 2011 Dec 7.
8
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.抗癌治疗期间出现的有症状毒性:三项随机试验中患者报告和医生报告的一致性。
J Clin Oncol. 2015 Mar 10;33(8):910-5. doi: 10.1200/JCO.2014.57.9334. Epub 2015 Jan 26.
9
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.在一项2期癌症治疗试验期间,与临床研究人员共享患者报告的症状毒性和体能状态的可行性及临床影响。
Clin Trials. 2016 Jun;13(3):331-7. doi: 10.1177/1740774515615540. Epub 2015 Nov 4.
10
Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial.评估 EORTC 患者报告结局测量在混合癌症患者人群中提高 CTCAE 评分的观察者间可靠性的应用:一项随机对照试验的研究方案。
Trials. 2020 Oct 13;21(1):849. doi: 10.1186/s13063-020-04745-w.

引用本文的文献

1
Neurosurgical nurses' perspectives of patient-reported outcomes: a qualitative study.神经外科护士对患者报告结局的看法:一项定性研究。
BMC Nurs. 2025 Aug 11;24(1):1047. doi: 10.1186/s12912-025-03726-1.
2
Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review.抗抑郁药撤药的证据:对近期一项系统评价的评估与重新分析
Psychol Med. 2025 Jul 22;55:e191. doi: 10.1017/S0033291725100652.
3
Effectiveness of symptom monitoring on electronic patient-reported outcomes (ePROs) among patients with lung cancer: a systematic review and meta-analysis.症状监测对肺癌患者电子患者报告结局(ePROs)的有效性:一项系统评价和荟萃分析。
NPJ Digit Med. 2025 Jul 3;8(1):399. doi: 10.1038/s41746-025-01812-x.
4
A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls.一项针对前列腺癌患者和对照组的全国性纵向患者报告结局收集研究。
Qual Life Res. 2025 Jul 2. doi: 10.1007/s11136-025-04017-7.
5
Remote symptom monitoring with patient-reported outcomes and nudges during lung cancer immunotherapy in China (PRO-NET): protocol for a randomised controlled trial.中国肺癌免疫治疗期间通过患者报告结局和助推进行远程症状监测(PRO-NET):一项随机对照试验的方案
BMJ Open. 2025 Jan 28;15(1):e093374. doi: 10.1136/bmjopen-2024-093374.
6
Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity.迈向盆腔癌的个性化放疗:晚期放射毒性的患者相关风险因素
Curr Oncol. 2025 Jan 17;32(1):47. doi: 10.3390/curroncol32010047.
7
[Pre-implementation of electronic patient-reported outcomes at reference centers for head and neck oncology : A roadmap towards patient-centered digitalization].[头颈肿瘤参考中心电子患者报告结局的实施前准备:以患者为中心的数字化路线图]
HNO. 2025 Feb;73(2):95-102. doi: 10.1007/s00106-024-01543-7. Epub 2025 Jan 16.
8
Engaging survivor and oncologist stakeholders to develop a patient-reported outcome assessment to use as a component of survivorship care.让幸存者和肿瘤学家利益相关者参与进来,以开发一种患者报告结局评估方法,用作幸存者护理的一个组成部分。
Support Care Cancer. 2024 Dec 9;33(1):9. doi: 10.1007/s00520-024-09022-z.
9
Development and validation of the self-report symptom inventory of immune-related adverse events in patients with lung cancer.肺癌患者免疫相关不良事件自我报告症状量表的编制与验证
Asia Pac J Oncol Nurs. 2024 Oct 12;11(12):100603. doi: 10.1016/j.apjon.2024.100603. eCollection 2024 Dec.
10
A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit.在癌症临床试验单位使用电子平台从患者收集不良事件数据的一项试点研究。
Drugs Real World Outcomes. 2024 Dec;11(4):725-734. doi: 10.1007/s40801-024-00461-y. Epub 2024 Nov 2.

本文引用的文献

1
Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugs.癌症药物临床试验中严重不良事件评估和报告方法的质量。
Clin Pharmacol Ther. 2010 Aug;88(2):231-6. doi: 10.1038/clpt.2010.79. Epub 2010 Jun 23.
2
The missing voice of patients in drug-safety reporting.药物安全报告中患者缺失的声音。
N Engl J Med. 2010 Mar 11;362(10):865-9. doi: 10.1056/NEJMp0911494.
3
Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.患者与临床医生报告的不良症状事件:与临床结局的关系
J Natl Cancer Inst. 2009 Dec 2;101(23):1624-32. doi: 10.1093/jnci/djp386. Epub 2009 Nov 17.
4
The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record.对不良事件的回顾性评估的组内一致性并不会因每位患者记录增加两名评审员而提高。
J Clin Epidemiol. 2010 Jan;63(1):94-102. doi: 10.1016/j.jclinepi.2009.03.004. Epub 2009 May 26.
5
Intraclass correlations: uses in assessing rater reliability.组内相关系数:在评估评分者可靠性中的应用。
Psychol Bull. 1979 Mar;86(2):420-8. doi: 10.1037//0033-2909.86.2.420.
6
Agreement between patient-reported symptoms and their documentation in the medical record.患者报告的症状与其病历记录之间的一致性。
Am J Manag Care. 2008 Aug;14(8):530-9.
7
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.通过电子患者报告结局对接受化疗的患者进行长期毒性监测。
J Clin Oncol. 2007 Dec 1;25(34):5374-80. doi: 10.1200/JCO.2007.11.2243.
8
Patient-reported outcomes and the evolution of adverse event reporting in oncology.患者报告的结局与肿瘤学中不良事件报告的演变
J Clin Oncol. 2007 Nov 10;25(32):5121-7. doi: 10.1200/JCO.2007.12.4784.
9
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.美国国立癌症研究所资助的临床试验网络所支持的临床试验中整合患者报告结局的问题与挑战。
J Clin Oncol. 2007 Nov 10;25(32):5051-7. doi: 10.1200/JCO.2007.11.3324.
10
Precision of health-related quality-of-life data compared with other clinical measures.与其他临床指标相比,健康相关生活质量数据的精确性。
Mayo Clin Proc. 2007 Oct;82(10):1244-54. doi: 10.4065/82.10.1244.